Department of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh 160014, India.
Department of Medical Parasitology, PGIMER, Chandigarh 160012, India.
ACS Appl Bio Mater. 2024 Aug 19;7(8):5279-5289. doi: 10.1021/acsabm.4c00498. Epub 2024 Jul 24.
Antibacterial photodynamic therapy (APDT) has received increased attention as a treatment for multidrug-resistant bacterial infections caused by antibiotic abuse. However, photosensitizers used in APDT have disadvantages such as water insolubility, self-aggregation, and photobleaching. To address these limitations, metal complexes have been explored. However, the use of such complexes tends to confine their antibacterial effectiveness specific bacterial strains. In this study, we report iron (Fe)- and copper (Cu)-based metallosurfactants as unique moieties for antibacterial photodynamic therapy (PDT) under the illumination of visible light. Briefly, our formulated Fe and Cu metallosurfactants, when combined with a fluorescein photosensitizer, exhibit nearly 100% antibacterial efficacy. This high efficiency is primarily attributed to the enhanced generation of singlet oxygen using FL in the presence of metallosurfactants when targeting bacteria such as and under laser light. In vitro experiments further confirmed the superior antimicrobial activity of these metallosurfactants against a diverse range of microbial cultures, encompassing Gram-negative and Gram-positive bacteria as well as fungi. This performance outpaces conventional surfactants like cetyltrimethylammonium chloride and cetylpyridinium chloride. The compelling results from MTT assays and flow cytometry endorsed the substantial enhancement in antimicrobial properties achieved through Fe and Cu doping, all without the need for additional secondary agents. Notably, this synergistic antibacterial approach using metallosurfactants in PDT holds significant promise for the elimination of various bacteria in vivo, with the added advantage of mitigating the emergence of multidrug resistance.
抗菌光动力疗法 (APDT) 作为一种治疗抗生素滥用引起的多药耐药细菌感染的方法受到了越来越多的关注。然而,APDT 中使用的光敏剂存在水溶性差、自聚集和光漂白等缺点。为了解决这些限制,人们探索了金属配合物。然而,这些配合物的使用往往会将其抗菌效果局限于特定的细菌菌株。在这项研究中,我们报告了铁 (Fe) 和铜 (Cu) 基金属表面活性剂作为在可见光照射下进行抗菌光动力疗法 (PDT) 的独特部分。简而言之,我们设计的 Fe 和 Cu 金属表面活性剂与荧光素光敏剂结合使用时,对 和 等细菌具有近 100%的抗菌功效。这种高效率主要归因于在金属表面活性剂存在下,使用 FL 靶向细菌时,单线态氧的生成增强。在激光照射下。体外实验进一步证实了这些金属表面活性剂对包括革兰氏阴性和革兰氏阳性细菌以及真菌在内的多种微生物培养物的卓越抗菌活性。这种性能优于传统表面活性剂,如十六烷基三甲基氯化铵和十六烷基吡啶氯。MTT 测定和流式细胞术的结果令人信服,证明通过 Fe 和 Cu 掺杂可显著增强抗菌性能,而无需额外的辅助剂。值得注意的是,这种使用金属表面活性剂的协同抗菌光动力疗法在体内消除各种细菌方面具有很大的潜力,并且具有减轻多药耐药性出现的优势。